» Articles » PMID: 16124283

Evaluation of Perfluorooctane Surfactants in a Wastewater Treatment System and in a Commercial Surface Protection Product

Overview
Date 2005 Aug 30
PMID 16124283
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The origin and amount of perfluorooctane surfactants in wastewater treatment systems, and the transformation these compounds may undergo during treatment, were evaluated through measurement and experiment. Influent, effluent, and river water at the point of discharge for a 6-MGD wastewater treatment plant (WWTP) were screened for eight perfluorooctane surfactants. N-EtFOSAA was quantified in influent (5.1 +/- 0.8 ng/L), effluent (3.6 +/- 0.2 ng/ L), and river water samples (1.2 +/- 0.3 ng/L), while PFOS and PFOA were quantified in effluent (26 +/- 2.0 and 22 +/- 2.1 ng/L, respectively) and river water (23 +/- 1.5 and 8.7 +/- 0.8 ng/L, respectively). Signals for PFOS and PFOA were observed in influent samples, but exact quantitative determination could not be made due to low recoveries of these two compounds in field spike samples. Although the source of PFOS and PFOA observed in WWTP effluents is not clear, two hypotheses were examined: (1) the highly substituted perfluorooctane surfactants that constitute commercially available fabric protectors can be transformed to PFOS and PFOA during biological treatment in wastewater treatment systems, and (2) the end products themselves are directly introduced to WWTPs because they are present as residual in the commercial mixtures. Biotransformation experiments of 96 h were run to determine whether N-EtFOSE (a primary monomer used in 3M's polymer surface protection products) could be transformed to lesser-substituted perfluorooctane compounds in bioreactors amended with aerobic and anaerobic sludge from the sampled plant. At the end of the aerobic biotransformation experiment, N-EtFOSAA and PFOSulfinate were the only two metabolites formed and each accounted for 23 +/- 5.0% and 5.3 +/- 0.8% of the transformed parent on a molar basis, respectively. Transformation of N-EtFOSE was not observed under anaerobic conditions. A sample of a commercially available surface protection product from 1994 was analyzed and found to contain six of the targeted perfluorinated surfactants, including PFOS and PFOA. These findings suggest transformation of precursors within wastewater treatment is not an important source of these compounds compared to direct use and disposal of products containing the end products as residual amounts.

Citing Articles

PFAS fate using lysimeters during degraded soil reclamation using biosolids.

Peter L, Modiri-Gharehveran M, Alvarez-Campos O, Evanylo G, Lee L J Environ Qual. 2024; 54(1):41-53.

PMID: 38816342 PMC: 11718147. DOI: 10.1002/jeq2.20576.


PFAS in Nigeria: Identifying data gaps that hinder assessments of ecotoxicological and human health impacts.

Kikanme K, Dennis N, Orikpete O, Ejike Ewim D Heliyon. 2024; 10(9):e29922.

PMID: 38694092 PMC: 11061687. DOI: 10.1016/j.heliyon.2024.e29922.


All-cause, cardiovascular disease and cancer mortality in the population of a large Italian area contaminated by perfluoroalkyl and polyfluoroalkyl substances (1980-2018).

Biggeri A, Stoppa G, Facciolo L, Fin G, Mancini S, Manno V Environ Health. 2024; 23(1):42.

PMID: 38627679 PMC: 11022451. DOI: 10.1186/s12940-024-01074-2.


A Review: Per- and Polyfluoroalkyl Substances-Biological Degradation.

Grgas D, Petrina A, Stefanac T, Beslo D, Landeka Dragicevic T Toxics. 2023; 11(5).

PMID: 37235260 PMC: 10220634. DOI: 10.3390/toxics11050446.


How the Structure of Per- and Polyfluoroalkyl Substances (PFAS) Influences Their Binding Potency to the Peroxisome Proliferator-Activated and Thyroid Hormone Receptors-An In Silico Screening Study.

Kowalska D, Sosnowska A, Bulawska N, Stepnik M, Besselink H, Behnisch P Molecules. 2023; 28(2).

PMID: 36677537 PMC: 9866891. DOI: 10.3390/molecules28020479.